CD40, but Not Lipopolysaccharide and Anti-IgM Stimulation of Primary B Lymphocytes, Leads to a Persistent Nuclear Accumulation of RelB

Journal of Immunology

Volumn 157, Issue 11, 1996, Pages 4862-4869

  Neumann, Manfred ^a,b   Wohlleben, Gisela ^b   Chuvpilo, Sergei ^a   Kistler, Barbara ^c   Wirth, Thomas ^c   Serfling, Edgar ^a   Schimpl, Anneliese ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Center for Molecular Biology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; CD40 ANTIGEN; CD40 LIGAND; GLOBIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; ONCOPROTEIN; PRIMER DNA; RELB PROTEIN, HUMAN; RELB PROTEIN, MOUSE; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELB;

ANIMAL; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; DBA MOUSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; REPORTER GENE; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS, CD40; B-LYMPHOCYTES; BASE SEQUENCE; CD40 LIGAND; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; DNA PRIMERS; GENE EXPRESSION REGULATION; GENES, REPORTER; GLOBINS; HUMANS; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED DBA; MICE, TRANSGENIC; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-REL; RNA; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS;

EID: 0030443871     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J. P. Gallizi, C. van Kooten, Y. J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881.
2. Tewari, M., and V. M. Dixit. 1996. Recent advances in tumor necrosis factor and CD40 signaling. Curr. Opin. Genet. Dev. 6:539.
3. Korthäuer, U., D. Graf, H. W. Mages, F. Briere, M. Padayachee, S. Malcolm, A. G. Ugazio, L. D. Notarangelo, R. J. Levinski, and R. A. Kroczek. 1993. Defective expression of T cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539.
4. Disanto, J. P., J. Y. Bonnefoy, J. F. Gauchat, A. Fischer, and G. Saint Basile. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 361:541.
5. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L. S. Grossmaire, R. Stenkamp, M. Neubauer, R. L. Roberts, R. J. Noelle, J. A. Ledbetter, U. Francke, and H. D. Ochs. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291.
6. Xu, J., T. M Foy, J. D. Laman, E. A. Elliot, J. J. Dunn, T. J. Waldschmidt, J. Elsemore, R. J. Noelle, and R. A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity 1:423.
7. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167.
8. Grilli, M., J.-S. Jason, and M. J. Lenardo. 1993. NF-κB and rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1.
9. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
10. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405.
11. Nabel, G., and I. M. Verma. 1993. Proposed NF-κB/IκB family nomenclature. Genes Der. 7:2063.
12. Beg, A. A., and A. S. Baldwin. 1993. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7:2064.
13. Liou, H.-C., and D. Baltimore. 1993. Regulation of the NF-κB/rel transcription factor and 1κB inhibitor system. Curr. Opin. Cell Biol. 5:477.
14. Köntgen, F., R. J. Grumonat, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965.
15. Sha, W., H.-C. Liou, E. I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to mullifocal defects in immune responses. Cell 80:321.
16. H transcription, and Ig class switching. J. Immunol. 156:183.
17. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167.
18. Weih, F., D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R. P. Ryseck, S. A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of ReIB, a member of the NF-κB/Rel family. Cell 80:331.
19. Burkly, L., C. Hession, L. Ogata, C. Reilly, L. A. Marconi, D. Olson, R. Tizard, R. Cate, and D. Lo. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373:531.
20. Beg, A. A., W. C. Sha, R. T. Bronson, and D. Baltimore. 1995. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice. Genes Dev. 9:2736.
21. Durie, F. H., T. M. Foy, S. R. Masters, J. D. Laman, and R. Noelle. 1994. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today 15:406.
22. Lernbecher, T., U. Müller, and T. Wirth. 1993. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 365:767.
23. a encoded determinants. J. Exp. Med. 171:1381.
24. Wohlleben, G., D. Gray, and A. Schimpl. 1996. In vitro immunization of naive mouse B cells: establishment of IgM secreting hybridomas specific for soluble protein or hapten from B cells cultured on CD40 ligand transfected mouse fibroblasts. Int. Immunol. 8:343.
25. Atchison, M. L., and R. P. Perry. 1987. The role of the κ enhancer and its binding factor NF-κB in the developmental regulation of κ gene transcription. Cell 48: 121.
26. Schreiber, E., P. Matthias, M. M. Müller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with 'mini-extracts,' prepared from a small number of cells. Nucleic Acids Res. 17:6419.
27. Briegel, K., B. Hentsch, I. Pfeuffer, and E. Serfling. 1991. One base pair change abolishes the T cell-restricted activity of a κB-like proto-enhancer element from the interleukin 2 promoter. Nucleic Acids Res. 19:5929.
28. Rice, N. R., M. L. MacKichan, and A. Israel. 1992. The precursor of NF-κB p50 has IκB-like functions. Cell 71:243.
29. Serfling, E., R. Barthelmäs, I. Pfeuffer, B. Schenk, S. Zarius, R. Sowoboda, F. Mercurio, and M. Karin. 1989. Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes. EMBO J. 8:465.
30. Berberich, I., G. L. Shu, and E. A. Clark. 1994. Cross-linking of CD40 on B cells rapidly activates nuclear factor-κB. J. Immunol. 153:4357.
31. Marcuzzi, A., B. van Ness, T. Rouse, and D. Lafrenz. 1989. Effects of anti-IgM suppression on polyclonally activated murine B cells: analysis of immunoglobulin mRNA, gene specific nuclear factors and cell cycle distribution. Nucleic Acids Res. 17:10455.
32. Liu, J., T. C. Chiles, R. Sen, and T. L. Rothstein. 1991. Inducible nuclear expression of NF-κB in primary B cells stimulated through the surface Ig receptor. J. Immunol. 146:1685.
33. Rooney, J. W., P. M. Dubois, and C. H. Sibley. 1991. Cross-linking of surface IgM activates NF-κB in B lymphocytes. Eur. J. Immunol. 21:2993.
34. Rothe, M., V. Sarma, V. M. Dixit, and D. V. Goeddel. 1995. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424.
35. Francis, D. A., J. G. Karras, X.-Y. Ke, R. Sen, and T. L. Rothstein. 1995. Induction of the transcription factors NF-κB, AP-1 and NF-AT during B cell stimulation through CD40 receptor. Int. Immunol. 7:151.
36. Atchison, M. L., and R. P. Perry. 1988. Complementation between two cell lines lacking κ enhancer activity: implications for the developmental control of immunoglobulin transcription. EMBO J. 7:4213.
37. Lernbecher, T., B. Kistler, and T. Wirth. 1994. Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. EMBO J. 13:4060.
38. c-rel. Mol. Cell. Biol. 11:5867.
39. Neumann, M., T. Grieshammer, S. Chuvpilo, B. Kneitz, M. Lohoff, A. Schimpl, B. R. Franza, and E. Serfling. 1995. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J. 14:1991.
40. Naumann, M., and C. Scheidereit. 1994. Activation of NF-κB in vivo is regulated by multiple phosphorylations. EMBO J. 13:4597.
41. Baker, S. J., and E. P. Reddy. 1996. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1.
42. Hsu, H., H.-B. Shu, M.-G. Pan, and D. V. Goeddel. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299.
43. Cheng, G., A. M. Cleary, Z.-S. Ye, D. I. Hong, S. Lederman, and D. Baltimore. 1995. Involvement of CRAF2, a relative of TRAF, in CD40 signaling. Science 267:1494.
44. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389.
45. Hu, M. H., K. O'Rourke, M. S. Boguski, and V. M. Dixit. 1994. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269:30069.
46. Paris, M., F. Gaskin, J. T. Parsons, and S. M. Fu. 1994. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinases Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein. J. Exp. Med. 179:1923.
47. Ren, C. L., T. Morio, S. M. Fu, and R. S. Geha. 1994. Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase Cγ2. J. Exp. Med. 179:673.
48. Berberich, I., G. Shu, F. Siebelt, J. R. Woodgett, J. M. Kyriakis, and E. A. Clark. 1996. Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases. EMBO J. 15:92.
49. Pessara, U., and N. Koch. 1990. Tumor necrosis factor γ regulates expression of the major histocompatibility complex class II-associaled invarianf chain by binding of a NF-κB-like factor to a promoter element. Mol. Cell. Biol. 10:4146.